Maternal & Neonatal Outcome in Pregnant Women Before & NCT02356744

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Recruiting

Ultrasound follow up for 9 months pregnancy in women underwent baraitric surgery before and after 1 year of surgery.

Ultrasound follow up for 9 months pregnancy in women who had laparoscopic adjustable gastric banding done within last 1 year or earlier.

Recruitment information / eligibility
Status	Recruiting
Enrollment	100
Est. completion date	January 2019
Est. primary completion date	January 2019
Accepts healthy volunteers	No
Gender	Female
Age group	18 Years to 39 Years
Eligibility	Inclusion Criteria: - 1.Pregnant women in third trimester 2.after laparoscopic adjustable gastric banding done within last 1 year or earlier Exclusion Criteria: - medical disorders affecting pregnancy as diabetes, hypertension, SLE

Other:
• Ultrasound
Ultrasound assessment of fetal growth, anomalies , liqour and placenta

Locations
Country	Name	City	State
Egypt	Kasr Alainy medical school	Cairo

Sponsors *(1)*
Lead Sponsor	Collaborator
Cairo University

Egypt,

Outcome
Type	Measure	Description	Time frame
Primary	maternal outcome	development of pregnancy complications as preeclampsia or gestational diabetes or postpartum complications as postpartum hemorrhage or puerperal sepsis	though 9 months of pregnancy and 6 weeks postpartum
Secondary	Neonatal outcome	Apgar score, neonatal ICU admission	2 weeks after birth
Secondary	Route of delivery	vaginal delivery or cesarean section and if cesarean its indications	time of delivery